Tata Cancer Hospital new drug research against cancer proves effective !

Three New drugs developed from Cancer tissues, HIV Virus, Hep C virus show anti-cancer effects in studies at ACTRECT (Tata) Institute, Mumbai

Drugs Made From Cancer Tissues and HIV Virus Found to be Effective Against Cancer, Says Research at Tata Institute

Key Highlights of the research paper

Three New drugs developed from Cancer tissues, HIV Virus, Hep C virus show anti-cancer effects in studies at ACTRECT (Tata) Institute, Mumbai Research by Indian doctor, involved in research for 20 years All the medicines inhibit and kill cancer cells in laboratory studies (cell lines) related to liver, cervix, lung, and breast cancers Further studies in animals and human trials will be carried out in future The study in a series of other experiments has irrefutable scientific evidence of the effects of homeopathic medicines Research papers have been published in international peer-reviewed journals and presented at prestigious conferences.

A scientific breakthrough in the field of homeopathy research shows hope for cancer treatment. The research was conducted at Tata Memorial's research facility ACTREC under the care of Dr. Rajesh Shah, Director, Homeopathy India Pvt Ltd. Initial results in cancer research with new homeopathic drugs developed from cancer tissues, HIV virus and Hepatitis C virus show unprecedented findings of inhibiting cancer cells in the laboratory model.

This novel research has shown positive effects of three new, high-dilution potentized homeopathic medicines, which are often criticized for lack of scientific evidence. The unique process called homeopathic potentization renders the drugs to be safe yet effective. The development has been lauded as the first-of-its-kind in over fifty years in the field of homeopathy. Dr. Rajesh Shah, the brain behind this path-breaking study was feted with the National Award by the Ministry of AYUSH last year for another drug-discovery,

Dr. Rajesh Shah sharing his insight on the research said, "I have been working on developing new homeopathic drugs. Our studies have shown the killing of cancer cells (apoptosis) as well as inhibition of the growth of cancer cells in different laboratory models. The drugs show anti-cancer activity on cell lines related to the liver, cervix, breast, and lung cancers. Earlier, HIV Nosode and Hepatitis C Nosode have also shown anti-cancer effects in studies in coordination with Dr. A.R. Khuda-Bukhsh, an eminent molecular biologist from Kalyani University, West Bengal. The development process started 15 years ago. I believe the initial results are encouraging."

Dr. Shah's experiments in laboratory models, animal studies, and human trials have shown irrefutable scientific evidence of the efficacy of homeopathy. Interestingly, scientists at IIT-B headed by Dr. Jayesh Bellare, a chemist, have shown the nanoparticles of the source materials in high-dilution homeopathic medicines, which were earlier believed to be containing some kind of 'energy'.

Dr. Raj K Manchanda, former Director-General of CCRH (Central Council for Research in Homeopathy), under Ministry of AYUSH, said, "Nosodes prepared from germs and diseased tissues are commonly used in homeopathic practice. Dr. Shah has scientifically developed new Nosodes from specific cancer tissues as well as a certain virus, using modern techniques. The Cancer Nosode, the HIV Nosode and the Hepatitis C Nosode demonstrate anti-cancer efficacy in cell-line models is strong preliminary evidence towards opening up many new research avenues. Further validation using this Nosode in animal and human models must be explored."

Dr. Vedang Murthy, a radiation oncologist and researcher at Tata Memorial Hospital Mumbai, observed, "Cancer is a very difficult disease to treat and we are always on the lookout for new approaches in its treatment. Early research in the laboratory with a drug prepared from cancer tissues has shown activity against cancer cells. Dr. Shah has shown preliminary results which should be strengthened by further research. These results may indicate some efficacy of homeopathy in the laboratory model. This seems like an early exploration of untapped potential of homeopathy against cancer."

Research papers have been published in international peer-reviewed journals and presented at prestigious conferences by Dr. Shah. The scientific monographs have been submitted to the concerned government departments for regulatory evaluation.

In the recent past, Dr. Shah has collaborated with about 35 scientists from seven institutions such as Haffkine Institute, IIT-Bombay, ICT, ACTREC, Nair Hospital, Mumbai University, etc. for experiments related to new drug discovery.

Tags : #Tata #Memorial #New #Drug #Cancer

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Serum Institute of India Partners with Oxford University to Develop Meningitis-B VaccineApril 18, 2024
Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income CountriesApril 18, 2024
Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024